FDA Import Refusal SCS-9540167-7/11/1 — Neurogan, Inc.
The FDA refused shipment SCS-9540167-7/11/1 from Neurogan, Inc. (United States) on February 11, 2022. The refused product falls under Drugs and Biologics — CANNABIDIOL (ANTI-CONVULSANT). Cited charges: 118,3280,75
Refusal Details
- Date
- February 11, 2022
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 61MCL49 CANNABIDIOL (ANTI-CONVULSANT)
- Charges
- 118,3280,75